Research To Practice | Oncology Videos

View Top 200 Chart

Back to Rankings Page

Science
**Research To Practice | Oncology Videos**

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

Latest Episodes:

ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists Sep 03, 2026

Show notes

Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics:

Introduction (0:00)
HER2 History (1:32)
Cases from the GMO Survey (7:06)
Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56)
Faculty Case Presentations (31:37)
Patterns of Care Survey — Part 1 (38:26)
Optimizing the Use of Up-Front Maintenance Therapy for HER2-Positive mBC — Dr Carey (44:53)
Faculty Case Presentations (54:13)

CME information and select publications

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program Sep 02, 2026

Show notes

Featuring perspectives from Dr William G Wierda, including the following topics:

Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00)
Sequencing Road Map (12:39)
Key Datasets — Pirtobrutinib (21:08)
Investigator Survey (34:09)
Chimeric Antigen Receptor T-Cell Therapy (45:08)
Other Novel Therapy Approaches (49:58)
EHA 2026 (54:45)

CME information and select publications

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal (Companion Faculty Lecture) Sep 01, 2026

Show notes

Description: Featuring a slide presentation and related discussion from Prof Ticiana Leal, including the following topics:

· Incidence, pathophysiology and clinical presentation (0:00)

· Diagnostic challenges and evaluation process (3:37)

· Treatment modalities and therapeutic options (10:01)

· Mechanistic effects and key clinical trial data for amifampridine (12:20)

· Key takeaways and conclusions (17:32)

CME information and select publications

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal Sep 01, 2026

Show notes

Featuring an interview with Prof Ticiana Leal, including the following topics:

Pathophysiology and clinical signs and symptoms (0:00)
Screening and/or diagnostic approaches (5:45)
Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
Key clinical trial data for amifampridine and practicalities of its administration (14:05)
Building awareness among patients, caregivers and the oncology community (22:37)
Role of pyridostigmine in managing Lambert-Eaton myasthenic syndrome (LEMS); potential integration of EMG (electromyography) into monitoring (25:35)
Case: A man in his early 70s who receives a diagnosis of limited-stage SCLC (LS-SCLC) with LEMS and undergoes treatment (27:41)
Case: A woman in her late 70s already diagnosed with LS-SCLC who is subsequently evaluated and treated for LEMS (37:55)
Current research and potential developments in the treatment of SCLC (48:32)

CME information and select publications

For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress Aug 31, 2026

Show notes

Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:

Introduction (0:00)
Overview of Prostate Cancer (3:00)
Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12)
Potential Role of Capivasertib in Metastatic HSPC (27:22)
Current and Potential Future Role of PARP Inhibitors in Metastatic PC (46:39)
Current and Future Role of Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic PC (1:09:14)

CME information and select publications

Metastatic Triple-Negative Breast Cancer — Patterns of Care Aug 28, 2026

Show notes

Featuring perspectives from Prof Peter Schmid and Dr Melinda Telli, including the following topics:

Introduction: TROP2-Targeting Antibody-Drug Conjugates (ADCs) for Metastatic Triple-Negative Breast Cancer (0:00)
First-Line Therapy (PD-L1 Negative) (6:53)
First-Line Therapy (PD-L1 Positive) (23:40)
Second-Line Therapy (Sequencing) (34:08)
Adverse Events with TROP2-Targeting ADCs (43:43)

CME information and select publications

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium Aug 27, 2026

Show notes

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:

Case: A patient with T4 disease, pelvic wall involvement and a positive pelvic node treated as metastatic disease with enfortumab vedotin and pembrolizumab attains a complete response on imaging after 6 cycles (0:00)
Case: A man with muscle-invasive bladder cancer who receives neoadjuvant chemotherapy with durvalumab receives positive circulating tumor DNA results before cystectomy and negative results after surgery (7:41)

CME information and select publications

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium Aug 26, 2026

Show notes

Featuring perspectives from Dr Terence Friedlander, Dr Matthew Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr Friedlander, including the following topics:

Case: A man in his early 80s with non-muscle-invasive bladder cancer (NMIBC) monitored by repeat TURBTs develops localized muscle-invasive bladder cancer and enrolls in a clinical trial of neoadjuvant enfortumab vedotin with pembrolizumab (0:00)
Case: A man in his late 70s with newly diagnosed NMIBC with carcinoma in situ (CIS) receives BCG induction and experiences relapse of CIS during BCG maintenance (9:24)

CME information and select publications

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances Aug 26, 2026

Show notes

Featuring perspectives from Dr Matthew Matasar and Dr Sonali M Smith, including the following topics:

Introduction: Lymphoma Survivorship (0:00)
Novel Treatment Approaches for Diffuse Large B-Cell Lymphoma — Dr Matasar (6:49)
Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymphoma — Dr Smith (32:14)

CME information and select publications

Non-Hodgkin Lymphoma | Sonali M Smith, MD Aug 25, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Novel Treatment Approaches for Non-Hodgkin Lymphoma | Faculty Presentation 2: Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymphoma — Sonali M Smith, MD

CME information and select publications

Our TOPPODCAST Picks

Follow Us

Stay Connected

Research To Practice | Oncology Videos

Related Podcasts

Links

Stay Connected